Authors
Sara S McCoy, Valeria Manfrè
Published in
Rheumatic diseases clinics of North America. Volume 53. Issue 1. Pages 65-80. Epub Oct 27, 2026.
Abstract
Sjögren's disease (SjD) is a systemic autoimmune disease traditionally attributed to lymphocytic infiltration and epithelial dysfunction and destruction. Growing evidence indicates that stromal cells might also contribute to local glandular pathology. This article focuses on stromal cell biology and immunobiology where stromal cells establish structural tissue integrity, tissue niches, and a regulatory immune environment. We highlight new data establishing stromal cells as players in SjD glandular immunobiology and pathology where they promote local tertiary lymphoid structure development and inflammatory cell chemotaxis. Finally, we review the growing data supporting mesenchymal stromal cells as a cellular therapeutic to treat SjD.
PMID:
43045334
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0